 Kura Oncology NASDAQ:KURA was upgraded by Zacks Investment Research from a hold rating to a buy rating in a research note issued to investors on Thursday, Zacks.com reports. The brokerage presently has a 11.00 price target on the stock. Zacks Investment Researchs price objective suggests a potential upside of 10.44 from the stocks current price. ... 